检查mate 77T:在早期NSCLC中,外科手术期间的化疗免疫疗法表现优于外科手术期间的化疗免疫疗法
Danielle Brazel1, Misako Nagasaka2
1Scripps Clinic/Scripps Green Hospital, Department of Hematology/Oncology, 10166 N Torrey Pines Road, La Jolla, CA 92037, USA.
Med (New York, N.Y.)
|August 10, 2024
概括
术后化学免疫疗法改善了非小细胞肺癌 (NSCLC) 患者的结局. 查克马特77T试验表明,在手术前和手术后添加尼沃卢马布给化疗改善了无事件生存率 (EFS).
科学领域:
- 医学瘤学 医学瘤学
- 胸部外科手术 胸部外科手术
- 免疫治疗是一种免疫疗法.
背景情况:
- 具有可切除疾病的非小细胞肺癌 (NSCLC) 约占病例的25%.
- 尽管有治疗意图的手术,但30%-50%的NSCLC患者经历了疾病复发.
- 新辅助,辅助和外科手术期间的化疗免疫疗法已在NSCLC中显示出改善的结果.
研究的目的:
- 为了评估术后化疗加尼沃卢马布加上手术和辅助尼沃卢马布在可切除的NSCLC中的疗效.
- 评估这种联合治疗策略对无事件生存 (EFS) 的影响.
主要方法:
- 查克马特77T试验研究了与尼沃卢马布结合的经手术期间基于的化疗.
- 患者在接受新辅助治疗后进行了手术切除.
- 辅助剂尼沃卢马布在手术后进行.
主要成果:
- 在外科手术期间的化疗免疫疗法证明了改善的结果.
- 在手术前和手术后,将尼沃卢马布添加到化疗中,显著提高了无事件生存率.
结论:
- 包括尼沃卢马布在内的外科化疗免疫疗法是可切除NSCLC的有希望的策略.
- 这种方法可以降低复发率并改善患者的长期结果.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
